Author: Sztabinska-Koncka H. Lewicki J.
Publisher: Academic Press
ISSN: 0273-2300
Source: Regulatory Toxicology and Pharmacology, Vol.26, Iss.1, 1997-08, pp. : 129-133
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Special aspects concerning the marketing authorization of RNA-based medicines
PHARMAKON, Vol. 3, Iss. 4, 2015-07 ,pp. :
Medicinal products in the treatment of alzheimer's disease
European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. :
Clinical investigation of medicinal products in the treatment of epileptic disorders
European Neuropsychopharmacology, Vol. 11, Iss. 3, 2001-06 ,pp. :